Efficient/JJ
transcription/NN
and/CC
replication/NN
of/IN
simian/JJ
immunodeficiency/NN
virus/NN
in/IN
the/DT
absence/NN
of/IN
NF-kappaB/NN
and/CC
Sp1/NN
binding/NN
elements/NNS
./.

Ten/CD
mutants/NNS
of/IN
the/DT
simian/JJ
immunodeficiency/NN
virus/NN
(/(
SIV/NN
)/)
SIVmac239/NN
bearing/VBG
deletions/NNS
(/(
delta/JJ|NNS
)/)
or/CC
substitutions/NNS
(/(
subst/JJ|NNS
)/)
in/IN
the/DT
NF-kappaB/NN
and/or/CC
Sp1/NN
binding/NN
elements/NNS
were/VBD
created/VBN
,/,
and/CC
the/DT
replicative/JJ
capacities/NNS
of/IN
the/DT
mutants/NNS
were/VBD
analyzed/VBN
./.
=====
All/DT
mutants/NNS
,/,
including/VBG
one/CD
extensively/RB
mutagenized/VBN
strain/NN
entirely/RB
missing/VBG
the/DT
NF-kappaB/NN
and/CC
four/CD
Spl/NN
binding/NN
elements/NNS
,/,
replicated/VBN
with/IN
wild-type/JJ
kinetics/NNS
and/CC
to/TO
a/DT
wild-type/JJ
level/NN
in/IN
peripheral/JJ
blood/NN
mononuclear/JJ
cell/NN
cultures/NNS
in/IN
50/CD
to/TO
100/CD
%/NN
of/IN
the/DT
experiments/NNS
./.
=====
One/CD
group/NN
of/IN
mutants/NNS
replicated/VBN
very/RB
similarly/RB
to/TO
SIVmac239/NN
in/IN
kinetics/NN
and/CC
yield/NN
in/IN
CEMxl74/NN
cells/NNS
(/(
2xNFKappaB/NN
>/JJ
or/CC
=/JJ
SlVmac239/NN
approximately/RB
deltaNFkappaB/NN
approximately/RB
deltaSpl234/NN
approximately/RB
substNFkappaB/NN
approximately/RB
substSpl2/NN
approximately/RB
substSp23/NN
)/)
,/,
while/IN
a/DT
second/JJ
group/NN
replicated/VBD
with/IN
delayed/VBN
or/CC
slightly/RB
delayed/VBN
kinetics/NN
in/IN
CEMxl74/NN
cells/NNS
(/(
SIVmac239/NN
>/JJ
substSp34/NN
>/JJ
deltaNFkappaBdeltaSpl234/NN
approximately/RB
deltaNFkappaBdeltaSp1/NN
>/JJ
substSpl234/NN
)/)
./.
=====
Reversions/NNS
or/CC
additional/JJ
mutations/NNS
were/VBD
not/RB
detected/VBN
in/IN
the/DT
U3/NN
and/CC
R/NN
regions/NNS
of/IN
proviral/JJ
DNA/NN
from/IN
CEMxl74/NN
cells/NNS
infected/VBN
with/IN
the/DT
SIVmac239/NN
mutants/NNS
./.
=====
Similar/JJ
results/NNS
were/VBD
obtained/VBN
when/WRB
mutants/NNS
of/IN
SIVmacMER/NN
(/(
a/DT
macrophage-competent/JJ
derivative/NN
of/IN
SIVmac239/NN
)/)
were/VBD
tested/VBN
in/IN
peripheral/JJ
blood/NN
mononuclear/JJ
cell/NN
and/CC
CEMx174/NN
cultures/NNS
./.
=====
However/RB
,/,
the/DT
growth/NN
of/IN
most/JJ
mutated/VBN
viruses/NNS
was/VBD
suppressed/VBN
in/IN
primary/JJ
rhesus/NN
monkey/NN
alveolar/JJ
macrophages/NNS
(/(
SIVmacMER/NN
approximately/RB
2xNFkappaB/NN
approximately/RB
substNFkappaB/NN
>/JJ
deltaNFkappaB/NN
>/JJ
deltaNFkappaBdeltaSpl234approximately/RB
deltaNFkappaBdeltaSpl/NN
>/JJ
deltaSpl234/NN
approximately/RB
substSpl2/NN
>/JJ
substSp23/NN
approximately/RB
substSp34/NN
approximately/RB
substSpl234/NN
>/JJ
or/CC
=/JJ
SIVmac239/NN
)/)
./.
=====
Thus/RB
,/,
changes/NNS
in/IN
the/DT
Sp1/NN
binding/NN
sites/NNS
had/VBD
the/DT
most/RBS
dramatic/JJ
effects/NNS
on/IN
SIVmac/NN
replication/NN
in/IN
primary/JJ
macrophage/NN
cultures/NNS
./.
=====
Analysis/NN
of/IN
long/JJ
terminal/JJ
repeat-driven/JJ
secreted/VBN
alkaline/NN
phosphatase/NN
activity/NN
in/IN
transient/JJ
assays/NNS
showed/VBD
that/IN
,/,
unlike/IN
human/JJ
immunodeficiency/NN
virus/NN
type/NN
1/CD
,/,
the/DT
SIV/NN
long/JJ
terminal/JJ
repeat/NN
possesses/VBZ
an/DT
enhancer/NN
region/NN
just/RB
upstream/RB
of/IN
the/DT
NF-kappaB/NN
element/NN
which/WDT
maintains/VBZ
significant/JJ
levels/NNS
of/IN
basal/JJ
transcription/NN
in/IN
the/DT
absence/NN
of/IN
NF-kappaB/NN
and/CC
Sp1/NN
sites/NNS
./.
=====
This/DT
region/NN
is/VBZ
responsive/JJ
to/TO
transactivation/NN
by/IN
Tat/NN
./.
=====
In/IN
addition/NN
,/,
the/DT
SIV/NN
TATA/NN
box/NN
was/VBD
shown/VBN
to/TO
be/VB
stronger/JJR
than/IN
that/DT
of/IN
human/JJ
immunodeficiency/NN
virus/NN
type/NN
1/CD
./.
=====
Therefore/RB
,/,
the/DT
surprisingly/RB
high/JJ
replicative/JJ
capacity/NN
of/IN
NF-kappaB/NN
and/CC
Sp1/NN
binding/NN
site/NN
mutants/NNS
of/IN
SIVmac/NN
is/VBZ
due/JJ
to/TO
unique/JJ
features/NNS
or/CC
the/DT
enhancer/promoter/NN
region/NN
./.